HEOR News Roundup

Tuesday, October 22, 2019 | Issue 474

Subscribe Contact Advertise HEOR & RWE Marketplace

Sponsored by

Study Finds Little Teeth in States'
Drug Pricing Transparency Measures

The authors of a recent study suggest that less than five percent of state laws passed in the last few years will have much impact on boosting drug pricing transparency, FiercePharma reports.

Read More

Frakt: Thin Evidence Base for Health Policies


A Look at the ‘Drug Pricing Maze’


Hart Expresses Concern Over Value Assessments in Coverage Decisions


Whistleblower Claims Fraud at Seattle Health Plan

 

   Conference

 

2nd Annual MarketsandMarkets Real-World Data and Life Science Analytics Congress

October 24-25 | Boston, Maryland

 

   Webinar

 

Launch Strategies: Trends and Challenges for Biotech Companies

October 23

 
 
Syndicated Reports
   
Global Value-Based Reimbursement Software Market Size, Status and Forecast to 2026
 
Benchmarking Key Account Management Capabilities (2019)
 
White Papers
   
The New Health Economy is Here. Do You Have the Right Knowledge Resources in Place?
 
The Link Between Drug Prices and Research on the Next Generation of Cures
 
 
  Director, Real World Value and Evidence, Pulmonary Hypertension (formerly HEOR) Director, Real World Market Access Analytics Communications Manager Senior/Principal Health Economist  
 
 
 
 

Share this newsletter!